Differences in the pharmacokinetics of flumequine after single and continuous oral administration in non-fasted broiler chickens. 2018

H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland.

The aim of this study was to determine the influence of feed on the pharmacokinetics of flumequine (FLU) administered to broiler chickens as follows: directly into the crop (10 mg/kg of BW) of fasted (group I/control) and non-fasted chickens (group II), or administered continu- ously with drinking water (1 g/L for 72 h) and with unlimited access to feed (group III). Plasma concentration of FLU was determined by high-performance liquid chromatography with fluo- rescence detection. In group II, a significant decrease in the maximum concentration (Cmax = 2.13±0.7 μg/mL) and the area under the concentration curve from zero to infinity (AUC0→∞ = 7.47±2.41 μg·h/mL) was noted as compared to the control group (Cmax = 4.11±1.68 μg/mL and AUC0→∞ = 18.17±6.85 μg·h/mL, respectively). In group III, the decrease in AUC was signifi- cant only in the first 3 hours (AUC0→3 = 5.02±1.34 μg·h/mL) as compared to the control group (AUC0→3 = 7.79±3.29 μg·h/mL). The results indicate that feed reduced the bioavailability of FLU from the gastrointestinal tract by at least 50% after the administration of a single oral dose. However, continuous administration of FLU with drinking water could compensate for the feed-induced decrease in absorption after single oral dose.

UI MeSH Term Description Entries
D008297 Male Males
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000821 Animal Feed Foodstuff used especially for domestic and laboratory animals, or livestock. Fodder,Animal Feeds,Feed, Animal,Feeds, Animal,Fodders
D000892 Anti-Infective Agents, Urinary Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. Antiseptics, Urinary,Antiinfective Agents, Urinary,Urinary Anti-Infective Agents,Urinary Antiinfective Agents,Agents, Urinary Anti-Infective,Agents, Urinary Antiinfective,Anti Infective Agents, Urinary,Urinary Anti Infective Agents,Urinary Antiseptics
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
December 2018, Journal of veterinary pharmacology and therapeutics,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
June 2000, Journal of veterinary pharmacology and therapeutics,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
August 2007, Veterinary research communications,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
October 2010, Journal of veterinary pharmacology and therapeutics,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
August 1997, Journal of veterinary pharmacology and therapeutics,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
January 2012, British poultry science,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
January 2001, Acta veterinaria Hungarica,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
April 2007, Journal of veterinary pharmacology and therapeutics,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
August 2023, Metabolites,
H Madej-Śmiechowska, and A Orzoł, and A Jasiecka-Mikołajczyk, and H Ziółkowski, and J J Jaroszewski
March 2018, Biomedical chromatography : BMC,
Copied contents to your clipboard!